Health authorities in the UK have reported 41,385 new positive coronavirus tests, the highest number yet recorded in a single day since the start of the pandemic.
Coronavirus live news: UK reports record 41,385 new daily cases; UK and South African variants now in Finland | World news | The Guardian
But at least we can also read about German efficiency -
Coronavirus live news: UK reports record 41,385 new daily cases; UK and South African variants now in Finland | World news | The Guardian
But at least we can also read about German efficiency -
Germany’s vaccination campaign has been overshadowed by a mishap in the north of the country, where eight workers in a care home received an overdose.
Vorpommern-Ruegen district authorities said the workers in Stralsund city received five times the recommended dose of the BioNTech/Pfizer vaccine on Sunday. Four went to hospital for observation after developing flu-like symptoms. The district chief Stefan Kerth said:
I deeply regret the incident. This individual case is due to individual errors. I hope that all those affected do not experience any serious side-effects.
The incident came after some German districts declined to use vaccines received over the weekend on suspicion that cold conditions were interrupted during delivery.
Vorpommern-Ruegen authorities pointed to previous statements by BioNTech saying larger doses were tested in the phase 1 study without serious consequences. There was no immediate comment from the pharmaceutical companies.
Vorpommern-Ruegen district authorities said the workers in Stralsund city received five times the recommended dose of the BioNTech/Pfizer vaccine on Sunday. Four went to hospital for observation after developing flu-like symptoms. The district chief Stefan Kerth said:
I deeply regret the incident. This individual case is due to individual errors. I hope that all those affected do not experience any serious side-effects.
The incident came after some German districts declined to use vaccines received over the weekend on suspicion that cold conditions were interrupted during delivery.
Vorpommern-Ruegen authorities pointed to previous statements by BioNTech saying larger doses were tested in the phase 1 study without serious consequences. There was no immediate comment from the pharmaceutical companies.
Comment